First Time Loading...

Biogaia AB
OTC:BGAIF

Watchlist Manager
Biogaia AB Logo
Biogaia AB
OTC:BGAIF
Watchlist
Price: 10.04 USD Market Closed
Updated: Apr 26, 2024

Intrinsic Value

BGAIF price has not been updated for more than 8 months. This may indicate that the stock has been delisted.

BioGaia AB engages in the development, marketing, and sale of probiotic products. [ Read More ]

The intrinsic value of one BGAIF stock under the Base Case scenario is 2.4 USD. Compared to the current market price of 10.04 USD, Biogaia AB is Overvalued by 76%.

Key Points:
BGAIF Intrinsic Value
Base Case
2.4 USD
Overvaluation 76%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biogaia AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BGAIF stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Biogaia AB

Provide an overview of the primary business activities
of Biogaia AB.

What unique competitive advantages
does Biogaia AB hold over its rivals?

What risks and challenges
does Biogaia AB face in the near future?

Summarize the latest earnings call
of Biogaia AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biogaia AB.

Provide P/S
for Biogaia AB.

Provide P/E
for Biogaia AB.

Provide P/OCF
for Biogaia AB.

Provide P/FCFE
for Biogaia AB.

Provide P/B
for Biogaia AB.

Provide EV/S
for Biogaia AB.

Provide EV/GP
for Biogaia AB.

Provide EV/EBITDA
for Biogaia AB.

Provide EV/EBIT
for Biogaia AB.

Provide EV/OCF
for Biogaia AB.

Provide EV/FCFF
for Biogaia AB.

Provide EV/IC
for Biogaia AB.

Show me price targets
for Biogaia AB made by professional analysts.

What are the Revenue projections
for Biogaia AB?

How accurate were the past Revenue estimates
for Biogaia AB?

What are the Net Income projections
for Biogaia AB?

How accurate were the past Net Income estimates
for Biogaia AB?

What are the EPS projections
for Biogaia AB?

How accurate were the past EPS estimates
for Biogaia AB?

What are the EBIT projections
for Biogaia AB?

How accurate were the past EBIT estimates
for Biogaia AB?

Compare the revenue forecasts
for Biogaia AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biogaia AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biogaia AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biogaia AB compared to its peers.

Compare the P/E ratios
of Biogaia AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Biogaia AB with its peers.

Analyze the financial leverage
of Biogaia AB compared to its main competitors.

Show all profitability ratios
for Biogaia AB.

Provide ROE
for Biogaia AB.

Provide ROA
for Biogaia AB.

Provide ROIC
for Biogaia AB.

Provide ROCE
for Biogaia AB.

Provide Gross Margin
for Biogaia AB.

Provide Operating Margin
for Biogaia AB.

Provide Net Margin
for Biogaia AB.

Provide FCF Margin
for Biogaia AB.

Show all solvency ratios
for Biogaia AB.

Provide D/E Ratio
for Biogaia AB.

Provide D/A Ratio
for Biogaia AB.

Provide Interest Coverage Ratio
for Biogaia AB.

Provide Altman Z-Score Ratio
for Biogaia AB.

Provide Quick Ratio
for Biogaia AB.

Provide Current Ratio
for Biogaia AB.

Provide Cash Ratio
for Biogaia AB.

What is the historical Revenue growth
over the last 5 years for Biogaia AB?

What is the historical Net Income growth
over the last 5 years for Biogaia AB?

What is the current Free Cash Flow
of Biogaia AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biogaia AB.

Financials

Balance Sheet Decomposition
Biogaia AB

Current Assets 1.9B
Cash & Short-Term Investments 1.5B
Other Current Assets 330.2m
Non-Current Assets 458.8m
Long-Term Investments 28.1m
PP&E 213.3m
Intangibles 211.4m
Other Non-Current Assets 6m
Current Liabilities 195.7m
Other Current Liabilities 195.7m
Non-Current Liabilities 107.1m
Other Non-Current Liabilities 107.1m
Efficiency

Earnings Waterfall
Biogaia AB

Revenue
1.3B SEK
Cost of Revenue
-346.3m SEK
Gross Profit
950.2m SEK
Operating Expenses
-507.1m SEK
Operating Income
443.1m SEK
Other Expenses
-77.8m SEK
Net Income
365.4m SEK

Free Cash Flow Analysis
Biogaia AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

BGAIF Profitability Score
Profitability Due Diligence

Biogaia AB's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Exceptional ROIC
76/100
Profitability
Score

Biogaia AB's profitability score is 76/100. The higher the profitability score, the more profitable the company is.

BGAIF Solvency Score
Solvency Due Diligence

Biogaia AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Biogaia AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BGAIF Price Targets Summary
Biogaia AB

Wall Street analysts forecast BGAIF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGAIF is 13.59 USD .

Lowest
Price Target
Not Available
Average
Price Target
13.59 USD
35% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

BIOG B Price
Biogaia AB

1M 1M
-14%
6M 6M
+15%
1Y 1Y
+19%
3Y 3Y
+40%
5Y 5Y
+32%
10Y 10Y
+254%
Annual Price Range
113.8
52w Low
92.7
52w High
133.8
Price Metrics
Average Annual Return 1.36%
Standard Deviation of Annual Returns 20.27%
Max Drawdown -99%
Shares Statistics
Market Capitalization 11.5B SEK
Shares Outstanding 100 982 310
Percentage of Shares Shorted
N/A

BIOG B Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Biogaia AB Logo
Biogaia AB

Country

Sweden

Industry

Biotechnology

Market Cap

11.5B USD

Dividend Yield

0%

Description

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

Contact

STOCKHOLM
Stockholm
Kungsbroplan 3
+46855529300.0
https://sv.biogaia.com/

IPO

1998-01-01

Employees

159

Officers

Founder & Chairman
Mr. Peter Rothschild M.Sc. Econ., MBA
Executive VP & CFO
Mr. Alexander Kotsinas M.Sc. (Eng.).
CEO & President
Ms. Theresa P. Agnew
Chief Operating Officer
Ludvig Milesson
Chief Scientific Officer and VP of Research & Development
Mr. Gianfranco Grompone
Chief Legal Officer
Ms. Caroline Mofors
Show More
Vice President of Marketing
Ms. Linda Hagglund
Chief HR Officer
Ms. Angelika Kjelldorff
VP & Chief Commercial Officer
Sebastian Heimfors
Sustainability Manager
Jonathan Gromark
Show Less

See Also

Discover More
What is the Intrinsic Value of one BGAIF stock?

The intrinsic value of one BGAIF stock under the Base Case scenario is 2.4 USD.

Is BGAIF stock undervalued or overvalued?

Compared to the current market price of 10.04 USD, Biogaia AB is Overvalued by 76%.